Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 841–848 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Belite Bio Inc Tinlarebant - (PHOENIX) Geographic Atrophy (GA) Phase 3 Enrollment Initiation Oral Opthalmic
Belite Bio Inc Tinlarebant - (DRAGON II) Stargardt Disease Phase 2/3 Enrollment Initiation Oral #N/A
Belite Bio Inc Tinlarebant (a/k/a LBS-008) Adolescent STGD1 Phase 2/3 Trial Planned Oral Genetic Disorder
Belite Bio Inc Tinlarebant - (LBS-008) Dry Age-Related Macular Degeneration (AMD) Phase 2/3 Ongoing Oral Opthalmic
Bellerophon Therapeutics Inc. INOpulse delivery device - (REBUILD) Pulmonary hypertension associated with Fibrotic Interstitial Lung Disease Phase 3 Trial Discontinued Inhalation Respiratory
Bellerophon Therapeutics Inc. INOpulse Inhaled Nitric Oxide COVID-19 Phase 3 Inhalation COVID-19
Bellerophon Therapeutics Inc. INOpulse Fibrotic interstitial lung disease (fILD) Phase 3 Trial Discontinued Inhalation Respiratory
Bellerophon Therapeutics Inc. INOpulse Pulmonary Hypertension-Sarcoidosis (PH-Sarc) Phase 2 Inhalation Respiratory